Zimmer Biomet has grown revenue 5.8% a year over three years and 4.2% a year over five, with earnings per share compounding at 22%. Revenue growth, 3-year annual rate: +5.8% (Medical Devices median +9.2%). Revenue growth, 5-year rate: +4.2%, growth has picked up over the last three years. Earnings per share, 3-year rate: +22%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

ZBHZimmer Biomet

HealthcareUSD

$101.36

$79.5852 weeks$106.87

Is it growing?

Is ZBH growing?

Zimmer Biomet has grown revenue 5.8% a year over three years and 4.2% a year over five, with earnings per share compounding at 22%.

+5.8%

Revenue growth, 3-year annual rate · Medical Devices median +9.2% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +4.2%
Revenue growth, 5-year rate · +5.8% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +22%
Earnings per share, 3-year rate · revenue +5.8% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed